Malaria: Focus on Prevention and Get the African Privileged Engaged

by Dr. K Amponsah-Manager I have written on malaria in the past. Since then, much has changed and nothing has changed. There are more than 400 million cases of malaria annually. Most of malaria infections and deaths occur in Sub-Saharan African where the most vulnerable are infants, pregnant mothers and seniors. In fact, it is… Continue reading Malaria: Focus on Prevention and Get the African Privileged Engaged

Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals

The United States Food and Drug Administration (FDA) has granted Glenmark Pharmaceuticals final approval to sell a generic version of GlaxoSmithKline (GSK) malaria drug Malarone. In April 2010, Glenmark settled a patent litigation with GlaxoSmithKline over atovaquone and proguanil hydrochloride 250 milligram/100mg tablets–the generic version of Malarone. The Indian company can sell the generic tablets… Continue reading Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals

Eradicating malaria in Sub-saharan Africa, Yes We Can

As promised last week, this is a response to the recommendations by the international team of experts on what governments and organizations should be doing with malaria.